FGFR1 Amplification in Metastatic Squamous Cell Carcinoma of the Head and Neck A Potential Target for a Rational Therapy?

被引：0
|
作者：
Goeke, F. [1 ]
Franzen, A. [1 ]
Mennon, R. [1 ]
Kirsten, R. [1 ]
Boehm, D. [1 ]
Vogel, W. [1 ]
Bootz, F. [1 ]
Schroeck, A. [1 ]
Perner, S. [1 ]
机构：
[1] Univ Hosp Bonn, Bonn, Germany
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1301
引用
收藏
页码：309A / 309A
页数：1
相关论文
共 50 条
  • [21] Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma
    von Maessenhausen, Anne
    Deng, Mario
    Billig, Hannah
    Queisser, Angela
    Vogel, Wenzel
    Kristiansen, Glen
    Schroeck, Andreas
    Bootz, Friedrich
    Goeke, Friederike
    Franzen, Alina
    Heasley, Lynn
    Kirfel, Jutta
    Braegelmann, Johannes
    Perner, Sven
    TARGETED ONCOLOGY, 2016, 11 (05) : 631 - 642
  • [22] Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Mennon, R.
    Scheble, V.
    Goltz, D.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Schroeck, A.
    Perner, S.
    MODERN PATHOLOGY, 2012, 25 : 477A - 477A
  • [23] Rationale for treatment of metastatic squamous cell carcinoma of the lung using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Schroeck, A.
    Scheble, V.
    Kirsten, R.
    Menon, R.
    Goltz, D.
    Boehm, D.
    Vogel, W.
    Perner, S.
    VIRCHOWS ARCHIV, 2012, 461 : S51 - S51
  • [24] Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Menon, R.
    Goltz, D.
    Scheble, V.
    Kirsten, R.
    Vogel, W.
    Boehm, D.
    Schroeck, A.
    Perner, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S195 - S195
  • [25] Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Mennon, R.
    Scheble, V.
    Goltz, D.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Schroeck, A.
    Perner, S.
    LABORATORY INVESTIGATION, 2012, 92 : 477A - 477A
  • [26] Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma
    Kono, Michihisa
    Komatsuda, Hiroki
    Yamaki, Hidekiyo
    Kumai, Takumi
    Hayashi, Ryusuke
    Wakisaka, Risa
    Nagato, Toshihiro
    Ohkuri, Takayuki
    Kosaka, Akemi
    Ohara, Kenzo
    Kishibe, Kan
    Takahara, Miki
    Katada, Akihiro
    Hayashi, Tatsuya
    Kobayashi, Hiroya
    Harabuchi, Yasuaki
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [27] FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma
    von Loga, Katharina
    Kohlhaussen, Jule
    Burkhardt, Lia
    Simon, Ronald
    Steurer, Stefan
    Burdak-Rothkamm, Susanne
    Jacobsen, Frank
    Sauter, Guido
    Krech, Till
    PLOS ONE, 2015, 10 (11):
  • [28] FGFR1 amplification in lung squamous cell carcinoma: A systematic review with meta-analysis
    Jiang, Tao
    Gao, Guanghui
    Fan, Guoxin
    Li, Mu
    Zhou, Caicun
    LUNG CANCER, 2015, 87 (01) : 1 - 7
  • [29] Clinical characteristics and natural history of patients with squamous cell lung carcinoma with FGFR1 amplification
    Bos, Marc Christiaan Allardt
    Gardizi, Masyar
    Heukamp, Lukas Carl
    Schildhaus, Hans-Ulrich
    Nogova, Lucia
    Ko, Yon-Dschun
    Schlesinger, Andreas
    Brockmann, Michael
    Serke, Monika Heidi
    Gerigk, Ulrich
    Hekmat, Khosro
    Stoelben, Erich
    Reiser, Marcel
    Engel-Riedel, Walburga
    Schnell, Roland
    Schmitz, Stephan H.
    Frank, Konrad
    Buettner, Reinhard
    Wolf, Juergen
    Zander, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Favorable Prognostic Implications of FGFR1 Amplification and MYC Amplification or Overexpression in Resected Esophageal Squamous Cell Carcinoma
    Kwon, Dohee
    Yun, Ji Y.
    Keam, Bhumsuk
    Kim, Young T.
    Jeon, Yoon K.
    MODERN PATHOLOGY, 2016, 29 : 473A - 473A
12345